Kinea Bio

About:

Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments.

Website: https://www.kineabio.com

Top Investors: Parent Project Muscular Dystrophy

Description:

Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments for neuromuscular illnesses.

Total Funding Amount:

$500000

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2020-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-02-13

IPO Status:

Private

Industries: